Matches in Nanopublications for { ?s ?p "[In addition to hydroxyurea, second-line cytotoxic chemotherapy agents and hematopoietic cell transplant have been used for aggressive forms of HES and CEL with outcomes reported for limited number of patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- NP310319.RA9O3PEf1IFWTCf9NHHdlaIP0DlkKz2EAB_cv0pJ5qw-U130_assertion description "[In addition to hydroxyurea, second-line cytotoxic chemotherapy agents and hematopoietic cell transplant have been used for aggressive forms of HES and CEL with outcomes reported for limited number of patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP310319.RA9O3PEf1IFWTCf9NHHdlaIP0DlkKz2EAB_cv0pJ5qw-U130_provenance.
- NP310230.RAZVFXRN0ds-qf907tn137Cwz251EkaSHdbfQR_0J86uE130_assertion description "[In addition to hydroxyurea, second-line cytotoxic chemotherapy agents and hematopoietic cell transplant have been used for aggressive forms of HES and CEL with outcomes reported for limited number of patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP310230.RAZVFXRN0ds-qf907tn137Cwz251EkaSHdbfQR_0J86uE130_provenance.
- NP310247.RAe4LVQ8PrAjmH4JaiEHYJ-JEeatwl-fWoZswczyd5hvY130_assertion description "[In addition to hydroxyurea, second-line cytotoxic chemotherapy agents and hematopoietic cell transplant have been used for aggressive forms of HES and CEL with outcomes reported for limited number of patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP310247.RAe4LVQ8PrAjmH4JaiEHYJ-JEeatwl-fWoZswczyd5hvY130_provenance.
- NP1158806.RAAhVte8HglLssPYXIkGnpOPP3XEnSuTZV8YVmOzmX0gA130_assertion description "[In addition to hydroxyurea, second-line cytotoxic chemotherapy agents and hematopoietic cell transplant have been used for aggressive forms of HES and CEL with outcomes reported for limited number of patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1158806.RAAhVte8HglLssPYXIkGnpOPP3XEnSuTZV8YVmOzmX0gA130_provenance.
- assertion description "[In addition to hydroxyurea, second-line cytotoxic chemotherapy agents and hematopoietic cell transplant have been used for aggressive forms of HES and CEL with outcomes reported for limited number of patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP310269.RAvWzVkxeE_xCZ6jWRUbDt2eLcKrx16oqDrYxPVV0_73o130_assertion description "[In addition to hydroxyurea, second-line cytotoxic chemotherapy agents and hematopoietic cell transplant have been used for aggressive forms of HES and CEL with outcomes reported for limited number of patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP310269.RAvWzVkxeE_xCZ6jWRUbDt2eLcKrx16oqDrYxPVV0_73o130_provenance.
- NP1158810.RAMj03erx8Eh4u1HnPl1pRyFsQbXjzkLYa4xcsu33e23M130_assertion description "[In addition to hydroxyurea, second-line cytotoxic chemotherapy agents and hematopoietic cell transplant have been used for aggressive forms of HES and CEL with outcomes reported for limited number of patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1158810.RAMj03erx8Eh4u1HnPl1pRyFsQbXjzkLYa4xcsu33e23M130_provenance.
- NP1158813.RAKdh9FZgLyYlAj59csIsz6PSfhYkh-8nNeryzYjYA-ak130_assertion description "[In addition to hydroxyurea, second-line cytotoxic chemotherapy agents and hematopoietic cell transplant have been used for aggressive forms of HES and CEL with outcomes reported for limited number of patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1158813.RAKdh9FZgLyYlAj59csIsz6PSfhYkh-8nNeryzYjYA-ak130_provenance.
- NP1158807.RAhpT8vzcoFNDVCVRP1HvpYBWcAxj50KRlUnItJrBwEVI130_assertion description "[In addition to hydroxyurea, second-line cytotoxic chemotherapy agents and hematopoietic cell transplant have been used for aggressive forms of HES and CEL with outcomes reported for limited number of patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1158807.RAhpT8vzcoFNDVCVRP1HvpYBWcAxj50KRlUnItJrBwEVI130_provenance.